Ann L. Macdougall - Net Worth and Insider Trading
Ann L. Macdougall Net Worth
The estimated net worth of Ann L. Macdougall is at least $540,596 dollars as of 2024-09-27. Ann L. Macdougall is the Director of Opiant Pharmaceuticals Inc and owns about 26,179 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $540,596. Details can be seen in Ann L. Macdougall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ann L. Macdougall has not made any transactions after 2022-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ann L. Macdougall
Ann L. Macdougall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ann L. Macdougall owns 2 companies in total, including Progenics Pharmaceuticals Inc (PGNX) , and Opiant Pharmaceuticals Inc (OPNT) .
Click here to see the complete history of Ann L. Macdougall’s form 4 insider trades.
Insider Ownership Summary of Ann L. Macdougall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | director |
| OPNT | Opiant Pharmaceuticals Inc | 2022-05-13 | director |
Ann L. Macdougall Latest Holdings Summary
Ann L. Macdougall currently owns a total of 1 stock. Ann L. Macdougall owns 26,179 shares of Opiant Pharmaceuticals Inc (OPNT) as of May 13, 2022, with a value of $540,596.
Latest Holdings of Ann L. Macdougall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OPNT | Opiant Pharmaceuticals Inc | 2022-05-13 | 26,179 | 20.65 | 540,596 |
Holding Weightings of Ann L. Macdougall
Ann L. Macdougall Form 4 Trading Tracker
According to the SEC Form 4 filings, Ann L. Macdougall has made a total of 3 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the acquisition of 3,000 shares on May 13, 2022, which cost Ann L. Macdougall around $32,790.
Insider Trading History of Ann L. Macdougall
- 1
Ann L. Macdougall Trading Performance
GuruFocus tracks the stock performance after each of Ann L. Macdougall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ann L. Macdougall is 4.87%. GuruFocus also compares Ann L. Macdougall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ann L. Macdougall within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ann L. Macdougall's insider trading performs compared to the benchmark.
Performance of Ann L. Macdougall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.55 | | | | | |
| Relative Return to S&P 500(%) | -9.88 | | | | | |
Ann L. Macdougall Ownership Network
Ann L. Macdougall Owned Company Details
What does Progenics Pharmaceuticals Inc do?
Who are the key executives at Progenics Pharmaceuticals Inc?
Ann L. Macdougall is the director of Progenics Pharmaceuticals Inc. Other key executives at Progenics Pharmaceuticals Inc include Chief Medical Officer Asha Das , 10 percent owner & other: See Explanation of Responses Balaji Venkataraman , and 10 percent owner & other: See Explanation of Responses Virinder Nohria .
Progenics Pharmaceuticals Inc (PGNX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Progenics Pharmaceuticals Inc (PGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Progenics Pharmaceuticals Inc (PGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Progenics Pharmaceuticals Inc (PGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Progenics Pharmaceuticals Inc Insider Transactions
Ann L. Macdougall Mailing Address
Above is the net worth, insider trading, and ownership report for Ann L. Macdougall. You might contact Ann L. Macdougall via mailing address: C/o Opiant Pharmaceuticals, Inc., 401 Wilshire Boulevard, 12th Floor, Santa Monica Ca 90401.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
